Rybix Odt is a drug owned by Shionogi Inc. It is protected by 2 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Dec 05, 2017. Details of Rybix Odt's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US6106861 | Multiparticulate tablet disintegrating in less than 40 seconds in the mouth |
Dec, 2017
(7 years ago) |
Expired
|
| US5464632 | Rapidly disintegratable multiparticular tablet |
Mar, 2013
(11 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Rybix Odt is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Rybix Odt's family patents as well as insights into ongoing legal events on those patents.
Rybix Odt's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Rybix Odt's generic launch date based on the expiry of its last outstanding patent is estimated to be Dec 05, 2017 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Rybix Odt Generic API suppliers:
Tramadol Hydrochloride is the generic name for the brand Rybix Odt. 28 different companies have already filed for the generic of Rybix Odt, with Sun Pharm having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Rybix Odt's generic
Alternative Brands for Rybix Odt
There are several other brand drugs using the same active ingredient (Tramadol Hydrochloride) as Rybix Odt. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |
|---|---|---|
| Athena |
| |
| Cipher Pharms Inc |
| |
| Janssen Pharms |
| |
| Kowa Pharms |
| |
| Purdue Pharma |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Tramadol Hydrochloride, Rybix Odt's active ingredient. Check the complete list of approved generic manufacturers for Rybix Odt
About Rybix Odt
Rybix Odt is a drug owned by Shionogi Inc. Rybix Odt uses Tramadol Hydrochloride as an active ingredient. Rybix Odt was launched by Shionogi Inc in 2005.
Approval Date:
Rybix Odt was approved by FDA for market use on 05 May, 2005.
Active Ingredient:
Rybix Odt uses Tramadol Hydrochloride as the active ingredient. Check out other Drugs and Companies using Tramadol Hydrochloride ingredient
Dosage:
Rybix Odt is available in tablet, orally disintegrating form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 50MG | TABLET, ORALLY DISINTEGRATING | Discontinued | ORAL |